Wakabayashi Y, Ishida J, Kotake F, Hirose M, Kawana K, Abe K, Amino S, Negishi Y, Akiya K
Dept. of Radiology, Tokyo Medical College Hospital.
Gan No Rinsho. 1989 Sep;35(10):1127-31.
Twenty-three patients previously diagnosed as having ovarian cancer were examined with both serum tumor markers (CA 125, CA 19-9, TPA, IAP, AFP) and a pelvic CT scan. The tumor markers predict the clinical outcome more accurately than the CT scan. Further, the tumor markers showed a clear correlation with the clinical course. But in one case, however, the tumor markers were seen to reduce below the normal level from chemotherapy, while the CT scan showed a tumor mass. Thus, both, a CT scan and tumor marker assays are felt to be indispensable for detecting the recurrence of an ovarian cancer.
对23名先前被诊断患有卵巢癌的患者进行了血清肿瘤标志物(CA 125、CA 19 - 9、TPA、IAP、AFP)和盆腔CT扫描检查。肿瘤标志物比CT扫描能更准确地预测临床结果。此外,肿瘤标志物与临床病程呈现明显相关性。然而,在1例患者中,化疗后肿瘤标志物降至正常水平以下,而CT扫描显示有肿瘤肿块。因此,CT扫描和肿瘤标志物检测对于检测卵巢癌复发均被认为是不可或缺的。